101 related articles for article (PubMed ID: 10650453)
41. Chronic electric stimulation of the midbrain ventral tegmental area increases spleen but not blood natural killer cell cytotoxicity in rats.
Wrona D; Klejbor I; Trojniar W
J Neuroimmunol; 2004 Oct; 155(1-2):85-93. PubMed ID: 15342199
[TBL] [Abstract][Full Text] [Related]
42. Natural killer cells: from "disturbing" background to central players of immune responses.
Hokland M; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):381-3. PubMed ID: 15607788
[No Abstract] [Full Text] [Related]
43. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
[TBL] [Abstract][Full Text] [Related]
44. Interaction between natural killer and dendritic cells: the role of CD40, CD80 and major histocompatibility complex class i molecules in cytotoxicity induction and interferon-gamma production.
Terrazzano G; Pisanti S; Grimaldi S; Sica M; Fontana S; Carbone E; Zappacosta S; Ruggiero G
Scand J Immunol; 2004 Apr; 59(4):356-62. PubMed ID: 15049779
[TBL] [Abstract][Full Text] [Related]
45. Signaling for cytotoxicity.
Perussia B
Nat Immunol; 2000 Nov; 1(5):372-4. PubMed ID: 11062493
[No Abstract] [Full Text] [Related]
46. Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse.
Yu Y; Wang Y; Feng M
Hum Immunol; 2008 Jan; 69(1):16-23. PubMed ID: 18295671
[TBL] [Abstract][Full Text] [Related]
47. Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function.
O'Connor GM; Holmes A; Mulcahy F; Gardiner CM
Clin Immunol; 2007 Sep; 124(3):277-83. PubMed ID: 17611161
[TBL] [Abstract][Full Text] [Related]
48. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity.
Fiore E; Fusco C; Romero P; Stamenkovic I
Oncogene; 2002 Aug; 21(34):5213-23. PubMed ID: 12149643
[TBL] [Abstract][Full Text] [Related]
49. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
Zhang X; Wei H; Wang H; Tian Z
Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
[TBL] [Abstract][Full Text] [Related]
50. [Age-related changes of the function and amount of natural killer cells in the liver: experiment with mice].
Zhao P; Bai XF; Yue X; Chi Q; Liu JZ; Hao XS
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1710-3. PubMed ID: 16854328
[TBL] [Abstract][Full Text] [Related]
51. Natural killer or dendritic: what's in a name?
Spits H; Lanier LL
Immunity; 2007 Jan; 26(1):11-6. PubMed ID: 17241957
[TBL] [Abstract][Full Text] [Related]
52. Natural killing activity and interferon production in multiple sclerosis.
Zander H; Abb J; Kaudewitz P; Riethmüller G
Lancet; 1982 Jan; 1(8266):280. PubMed ID: 6173558
[No Abstract] [Full Text] [Related]
53. Autologous cytotoxicity of natural killer cells derived from HIV-infected patients.
Hultström AL; Bratt G; Cosma A; Erfle V; Wahren B; Carbone E
Immunol Lett; 2004 Feb; 91(2-3):155-8. PubMed ID: 15019284
[TBL] [Abstract][Full Text] [Related]
54. Natural killer cell recognition of missing self.
Kärre K
Nat Immunol; 2008 May; 9(5):477-80. PubMed ID: 18425103
[No Abstract] [Full Text] [Related]
55. Regulation of natural-killer cell cytotoxicity and enhancement of complement factors in the spontaneously aborted mouse placenta.
Kusakabe K; Naka M; Ito Y; Eid N; Otsuki Y
Fertil Steril; 2008 Oct; 90(4 Suppl):1451-9. PubMed ID: 18068164
[TBL] [Abstract][Full Text] [Related]
56. The effects of a laboratory stressor on natural killer cell function in chronic fatigue syndrome patients.
Wemm KM; Trestman RL
Psychosomatics; 1991; 32(4):470-1. PubMed ID: 1961870
[No Abstract] [Full Text] [Related]
57. Signal transduction mechanisms in human natural killer cells mediating antitumor immunity.
Leibson PJ; Windebank KP; Barna TJ; Abraham RT
Haematol Blood Transfus; 1989; 32():281-3. PubMed ID: 2560445
[No Abstract] [Full Text] [Related]
58. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
59. Human neonatal natural killer cell cytotoxicity function.
Kohl S
Pediatr Infect Dis J; 1999 Jul; 18(7):635-7. PubMed ID: 10440443
[No Abstract] [Full Text] [Related]
60. Effector pathways of natural killer cells.
Van den Broek MF; Kägi D; Hengartner H
Curr Top Microbiol Immunol; 1998; 230():123-31. PubMed ID: 9586354
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
